SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Sharck Soup

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: besttrader who wrote (19028)4/27/2001 12:26:14 PM
From: Dave Gore  Read Replies (2) of 37746
 
Knight, no offense but you should do a little more DD before you invest. Of course these are lozenges, reading the press release would have told you that. It also tells you that they have conducted tests for seven months, so I would think they don't taste too bad. They are mint and euchalypus flavored. Couldn't taste worse than the coffee most people drink...lol!

SUGGEST YOU READ THIS....newset Press Release (not the whole release)

(REUTERS) Star Scientific developing tobacco lozenge
Star Scientific developing tobacco lozenge

By Brad Dorfman
NEW YORK, April 27 (Reuters) - Upstart tobacco company Star
Scientific Inc. <STSI.O> is hoping smokers will swallow the
idea of getting their nicotine in a lozenge.
The company is developing a smokeless hard tobacco product
that it calls a "cigalett" for use in places where smoking is
restricted.
The company said Friday that it would introduce the
product, which contains tobacco mixed with eucalyptus an mint
flavorings
, under the name Ariva. A spokeswoman could not say
when the product would be launched.
Chester, Virginia-based Star said it has reached an
agreement giving Brown & Williamson Tobacco Corp. exclusive
rights to sell the lozenges under its own brand. Star plans to
sell the lozenges under the Ariva brand. B&W, a unit of British
American Tobacco Plc <BATS.L>, is the No. 3 U.S. cigarette
maker.
Ariva will be the first hard smokeless tobacco product
developed in the U.S. that is "both taste-acceptable and
responsive to the needs of adult smokers who want an
alternative to cigarettes in the many smoke-free environments
they confront on a daily basis," Paul Perito, Star chairman and
president, said.
Star said Ariva contains less of the cancer-causing toxins,
TSNAs, than conventional smokeless tobacco products, but a
spokeswoman acknowledged that there is no empirical evidence
that reducing the toxins lowers the risk of cancer.
Ariva, which is about the size of a Tic-Tac mint, would
contain at least 60 percent tobacco. A recent Supreme Court
ruling on tobacco regulation could prohibit the Food and Drug
Administration from regulating the lozenges.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext